Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Shafer

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Preventive Medicine|September 11, 2016
Reasons for current E-cigarette use among U.S. adultsDeesha Patel, Kevin C Davis, Shanna Cox, et al.
BMC Developmental Biology|May 18, 2007
Novel subdomains of the mouse olfactory bulb defined by molecular heterogeneity in the nascent external plexiform and glomerular layersEric O Williams, Yuanyuan Xiao, Heather M Sickles, et al.
BMC Health Services Research|January 23, 2019
Does a transition to accountable care in Medicaid shift the modality of colorectal cancer testing?Melinda M Davis, Paul Shafer, Stephanie Renfro, et al.
Journal for Immunotherapy of Cancer|November 24, 2021
Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancerSaisha A Nalawade, Paul Shafer, Pradip Bajgain, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 21, 2025
ZP4: A novel target for CAR-T cell therapy in triple negative breast cancerLauren K Somes, Jonathan T Lei, Xinpei Yi, et al.
Blood|January 19, 2024
Targeting IDH2R140Q and other neoantigens in acute myeloid leukemiaWingchi K Leung, Alejandro G Torres Chavez, Matthew French-Kim, et al.
Cytotherapy|January 17, 2024
Incongruity between T cell receptor recognition of breast cancer hotspot mutations ESR1 Y537S and D538G following exogenous peptide loading versus endogenous antigen processingPaul Shafer, Wingchi K Leung, Mae Woods, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Preventive Medicine|September 11, 2016
Reasons for current E-cigarette use among U.S. adultsDeesha Patel, Kevin C Davis, Shanna Cox, et al.
BMC Developmental Biology|May 18, 2007
Novel subdomains of the mouse olfactory bulb defined by molecular heterogeneity in the nascent external plexiform and glomerular layersEric O Williams, Yuanyuan Xiao, Heather M Sickles, et al.
BMC Health Services Research|January 23, 2019
Does a transition to accountable care in Medicaid shift the modality of colorectal cancer testing?Melinda M Davis, Paul Shafer, Stephanie Renfro, et al.
Journal for Immunotherapy of Cancer|November 24, 2021
Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancerSaisha A Nalawade, Paul Shafer, Pradip Bajgain, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 21, 2025
ZP4: A novel target for CAR-T cell therapy in triple negative breast cancerLauren K Somes, Jonathan T Lei, Xinpei Yi, et al.
Blood|January 19, 2024
Targeting IDH2R140Q and other neoantigens in acute myeloid leukemiaWingchi K Leung, Alejandro G Torres Chavez, Matthew French-Kim, et al.
Cytotherapy|January 17, 2024
Incongruity between T cell receptor recognition of breast cancer hotspot mutations ESR1 Y537S and D538G following exogenous peptide loading versus endogenous antigen processingPaul Shafer, Wingchi K Leung, Mae Woods, et al.
Pageof 4